梦龙股价单日大跌19%，业绩下滑与行业压力成主因

Core Viewpoint - The significant decline in Menglong's stock price by 19.15% on February 12, 2026, is primarily attributed to its conservative future performance guidance and the release of its 2025 annual performance report [1] Financial Performance - In 2025, Menglong's net profit attributable to shareholders was 2.533 billion RMB, a decrease of 48.4% compared to 2024 [2] - The company incurred a total cash expenditure of 4.653 billion RMB to operate independently from Unilever, resulting in a drastic drop in free cash flow from 6.625 billion RMB in 2024 to 314 million RMB [2] Recent Events - Menglong's management anticipates an organic sales growth rate of only 3% to 5% for 2026, which is below market expectations, and has stated that no dividends will be paid before 2026 [3] - The company issued bonds totaling 24.75 billion RMB in 2025, leading to a significant increase in financial costs, raising investor concerns about its growth potential under high leverage [3] Industry and Risk Analysis - The popularity of GLP-1 weight loss drugs has reduced consumer demand for sweets, posing long-term pressure on high-premium ice cream brands like Menglong [4] - In the Chinese market, Menglong is clearing inventory through discount channels, with some products priced as low as 6 RMB, which may harm its brand premium ability, while facing intensified competition from local brands like Yili and Mengniu in the high-end market [4] Stock Performance - On February 12, Menglong's stock price hit a low of $15.97, with a daily volatility of 6.41% and a trading volume of approximately $623 million, indicating significant selling pressure [5] - The market is re-evaluating the "growing pains" of the independently operated company post-split, such as supply chain transition costs and inventory subsidy expenses, exacerbating pessimism regarding short-term profitability [5]